FORA Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

FORA Capital’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,961	Closed	-$890K	–	1213
2020 Q3	$890K	Buy	16,961 +7,773	+85%	+$322K	0.58%	32
2020 Q2	$306K	Buy	9,188 +851	+10%	+$27.1K	0.1%	246
2020 Q1	$227K	Buy	+8,337	New	+$232K	0.05%	425

FORA Capital's MNTA Position: Q4 2020 in Review

FORA Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 16,961 shares — an estimated $890K sold.

FORA Capital first reported a position in MNTA in Q1 2020 and held it in 3 quarters. The position peaked at $890K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

FORA Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
FORA Capital sold 16,961 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $890K.
FORA Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
FORA Capital's Momenta Pharmaceuticals, Inc. position peaked at $890K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.